Looking down the drug pipeline.
Cadman
J
J
D000225:Adenine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D000818:Animals; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001682:Biological Availability; D002722:Chlorobenzenes / Q000008:administration & dosage / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003062:Codon; D016048:Dideoxyadenosine / Q000031:analogs & derivatives*; D004352:Drug Resistance, Microbial; D015507:Drugs, Investigational; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D009281:Naphthalenes / Q000008:administration & dosage / Q000627:therapeutic use; D063065:Organophosphonates / Q000008:administration & dosage / Q000627:therapeutic use; D011744:Pyrimidinones; D019713:Receptors, CCR5 / Q000378:metabolism; D019718:Receptors, CXCR4 / Q000378:metabolism; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D000068698:Tenofovir
D019380:Anti-HIV Agents; D002722:Chlorobenzenes; D003062:Codon; D015507:Drugs, Investigational; D017320:HIV Protease Inhibitors; D009281:Naphthalenes; D063065:Organophosphonates; D011744:Pyrimidinones; D019713:Receptors, CCR5; D019718:Receptors, CXCR4; D018894:Reverse Transcriptase Inhibitors; D016048:Dideoxyadenosine; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D000068698:Tenofovir; D000225:Adenine; C106790:FP 21399